REQUEST A DEMO
Total
USD $0.00
Search more companies

Vesco Pharmaceutical Company Limited (Thailand)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Vesco Pharmaceutical Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Vesco Pharmaceutical Company Limited is a company in Thailand, with a head office in Bangkok , Special Governed District of. It operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on May 14, 2026. It currently has a total number of 110 (estimated) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 10.74% in 2024. Over the same period, its total assets grew by 19.63%. The net profit margin of Vesco Pharmaceutical Company Limited increased by 3.72% in 2024.

Headquarters
21/2 Phahon Yothin Road Soi Chaloem Suk
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10900

Contact Details: Purchase the Vesco Pharmaceutical Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Vesco Pharmaceutical Company Limited report to view the information.
Financial Auditors:
Purchase the Vesco Pharmaceutical Company Limited report to view the information.
Incorporation Date:
May 14, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Vesco Pharmaceutical Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
10.74%
Total Operating Revenue
10.87%
Operating Profit
79.19%
EBITDA
79.19%
Net Profit/Loss for the Period
88.48%
Total Assets
19.63%
Total Equity
16.6%
Operating Profit Margin
3.73%
Net Profit Margin
3.72%
Return on Equity (ROE)
5.87%
Quick Ratio
-0.9%
Cash Ratio
-0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?